Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Bureaucratic Delays Keep India’s Vulnerable From Receiving Life-Saving TB Treatment

Wall Street Journal: Inside India: The Deadly Effects of Red Tape Getta Anand, senior writer for the Wall Street Journal based in Mumbai “Red tape and over-regulation can kill. As Prime Minister Narendra Modi fights to loosen bureaucrats’ stifling grip on the economy, he also needs to ease Indians’ access…

7 Key Challenges Face Ebola Vaccine Developers, Stakeholders

The Lancet: Is the world ready for an Ebola vaccine? Bruce Y. Lee of the International Vaccine Access Center at Johns Hopkins Bloomberg School of Public Health and colleagues “…We propose seven key challenges to be considered early in Ebola vaccine development that will help stakeholders prepare and allow developers…

China Approves New Polio Vaccine, As Beijing Pushes To Lead Innovative Drug Market

Reuters: China approves new polio vaccine, shows innovative muscle “China has approved a new polio vaccine, the first of its kind to be produced in the country, a month after local authorities gave the green light for a home-grown Ebola vaccine amid Beijing’s push to become a world leader in…

India Rejects Gilead’s Hepatitis C Drug Patent Request; Decision Will Allow Local Companies To Make Generic Versions

Financial Times: India spurns Gilead over hepatitis C patent “India’s patent controller has rejected a patent application from Gilead Sciences for a key compound for its blockbuster hepatitis C drug Sovaldi, a refusal that activists said would allow Indian companies immediately to start producing cheap generic versions of the medicine…”…

Developing, Testing Ebola Vaccines Presents Major Challenges, Report Says

News services discuss a new report released Monday by the Wellcome Trust and CIDRAP titled, “Fast-Track Development of Ebola Vaccines: Principles and Target Product Criteria.” CIDRAP News: Report maps complex challenges to Ebola vaccine efforts “As experimental Ebola vaccines start to head toward large clinical trials in Africa, a report…

Partnership, Innovation Critical To Finding Quick Solutions To Disease Outbreaks

Forbes: Gates Foundation CEO: A Picture Of Hope In Early Ebola Vaccine Trials Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation “…Ebola surely won’t be the last crisis we face. Tackling today’s era of global challenges will require the enormous innovative capacity of business. It will require bold…

Richard Feachem Discusses Role Of Research, Policy, Private Sector In Malaria Response

Development Policy Centre’s “Devpolicy Blog”: Research, policy and the private sector: Sir Richard Feachem on malaria “…Professor Gabriele Bammer of the National Centre for Epidemiology and Population Health at ANU interviewed Sir Richard [Feachem, director of the Global Health Group at UCSF Global Health Sciences,] on the role of researchers,…

J&J Begins Human Trials Of Experimental Ebola Vaccine

Bloomberg News: J&J Injects First Volunteer in Race to Make Ebola Vaccine “Johnson & Johnson (JNJ) started a trial of its experimental Ebola vaccine in the U.K. and said it will produce two million courses of the shot this year…” (Bennett, 1/6). Reuters: J&J, Bavarian Nordic start clinical tests in…

Devex Examines Roles Of NGOs, Private Companies In Promoting Food Security

Devex: How companies and NGOs can work together to tackle food security “…Toward the end of last year, Devex Impact caught up separately with John Mendesh, General Mills’ vice president of research and development, and Brent Wibberley, director of PFS programs at TechnoServe, to talk to them about the private…